Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,160.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 140.00 (3.365%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Dec 2013 09:08

RNS Number : 7238V
North Atlantic Smlr Co Inv Tst PLC
17 December 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 OCTOBER 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 August 2013 to 31 October 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 October 2013

3 months %

6 months %

1 year 

%

3 years %

5 years %

Diluted NAV*

1,864p 

2.2 

8.4 

25.7

36.7 

84.9 

Mid-market price

1,588p 

6.4 

13.8 

38.0

52.0 

146.2 

Discount to diluted NAV *

14.8% 

Standard & Poor's 500 Composite Index **

1,095.1 

(1.2)

6.5 

25.1

48.4 

81.7 

Russell 2000 **

685.9 

(0.2)

12.4 

35.1

56.4 

105.1 

FTSE All-Share Index

3,585.3 

2.2 

5.8 

18.6

22.1 

64.2 

US Dollar/Sterling exchange rate

1.6066 

(6.0)

(3.2)

0.3

(0.5)

0.6 

 

* Following the conversion of the Loan Notes the performance is shown on the diluted NAV, excluding retained revenue for the period, only. The Board considers that this accurately reflects the underlying performance of the Company

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's holdings in Bionostics and Orthoproducts were sold at a good uplift to the year-end valuation and at a significant premium to cost. As a result, the Company now has cash or near cash balances of circa £80 million.

 

 

Transactions in Own Shares

 

On 26 September 2013, 1,450 Ordinary shares were bought back for cancellation, at a total cost to the Company of £22,000.

 

Since 31 October 2013, a further 13,483 Ordinary shares were bought back for cancellation, in two tranches, at the beginning of December 2013, at a total cost of £208,000.

 

Following these purchases the Company's issued share capital consists of 15,897,501 Ordinary shares.

 

 

 

TEN LARGEST INVESTMENTS AT 31 OCTOBER 2013

Gleeson (MJ) Group

UK Listed

11.5

US Treasury Bills

US Treasury Bills

18.8

Oryx International Growth Fund Limited *

UK Listed

11.5

Trident Private Equity Fund III LLP

UK Unquoted

8.3

Hampton Investment Properties Limited

UK Unquoted

5.2

Bioquell

UK Listed

4.7

Guinness Peat Group **

UK Listed

4.5

Celsis AG

US Unquoted

3.5

AssetCo PLC

UK Listed

2.8

Goals Soccer Centres

UK Listed

2.6

% of total portfolio

73.4

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 OCTOBER 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

20.5

20.5

Treasury Bills

18.8

18.8

Construction & Materials

11.5

11.5

Real Estate

0.2

7.6

0.4

8.2

Support Services

1.0

5.1

6.1

Industrial Engineering

5.1

5.1

Health Care, Equipment & Services

0.2

4.7

4.9

Financial Services

4.5

4.5

Travel & Leisure

3.5

3.5

Media

3.2

3.2

Banks

3.1

3.1

Escrows

1.7

0.4

2.1

Oil & Gas Producers

1.2

0.8

2.0

General Retailers

1.7

1.7

Technology Hardware & Equipment

1.5

1.5

Food Producers

1.3

1.3

Industrial Transportation

1.3

1.3

Business Services

0.7

0.7

 

The financial information for the period ended 31 October 2013 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

17 December 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGMMMZLNDGFZG
Date   Source Headline
21st May 201410:26 amRNSNotice of AGM
20th May 20144:58 pmRNSFinal Results
19th May 20149:30 amRNSHolding(s) in Company
14th May 20149:28 amRNSNet Asset Value(s)
30th Apr 20142:50 pmRNSHolding(s) in Company
30th Apr 20149:48 amRNSTransaction in Own Shares
14th Apr 20149:06 amRNSNet Asset Value(s)
18th Mar 20149:07 amRNSNet Asset Value(s)
26th Feb 20149:34 amRNSDirector/PDMR Shareholding
20th Feb 20143:00 pmRNSTransactions in a Close Period
12th Feb 20149:39 amRNSNet Asset Value(s)
20th Jan 20149:45 amRNSDirector/PDMR Shareholding
16th Jan 201411:13 amRNSDirector/PDMR Shareholding
15th Jan 20143:47 pmRNSDirector/PDMR Shareholding
14th Jan 20141:38 pmRNSNet Asset Value(s)
24th Dec 201312:37 pmRNSREPLACEMENT - Transaction in Own Shares
24th Dec 201312:29 pmRNSTransaction in Own Shares
17th Dec 20139:18 amRNSNet Asset Value(s)
17th Dec 20139:08 amRNSInterim Management Statement
9th Dec 20132:44 pmRNSTransaction in Own Shares
5th Dec 20135:08 pmRNSTransaction in Own Shares
12th Nov 201311:29 amRNSNet Asset Value(s)
4th Nov 20132:08 pmRNSHolding(s) in Company
11th Oct 201310:33 amRNSPortfolio Update
10th Oct 201310:25 amRNSNet Asset Value(s)
26th Sep 20134:35 pmRNSTransaction in Own Shares
26th Sep 20132:20 pmRNSHalf Yearly Report
17th Sep 20132:42 pmRNSHalf Yearly Report
12th Sep 201311:37 amRNSNet Asset Value(s)
20th Aug 20138:59 amRNSNet Asset Value(s)
2nd Aug 20131:06 pmRNSListing Rule 15.5.1(4)
18th Jul 20139:05 amRNSNet Asset Value(s)
26th Jun 20132:26 pmRNSDirector/PDMR Shareholding
26th Jun 20132:22 pmRNSResult of AGM
20th Jun 20139:36 amRNSTransaction in Own Shares
18th Jun 20133:01 pmRNSInterim Management Statement
18th Jun 201310:15 amRNSPortfolio Update
14th Jun 201311:33 amRNSNet Asset Value(s)
24th May 20137:00 amRNSAdditional Listing
22nd May 201312:11 pmRNSDoc re. Annual Report
22nd May 201310:06 amRNSHolding(s) in Company
16th May 201310:10 amRNSNet Asset Value(s)
15th May 201310:24 amRNSHolding(s) in Company
14th May 20133:52 pmRNSFinal Results
9th May 20137:30 amRNSTemporary Suspension - North Atlantic Smaller Comp
8th May 20139:02 amRNSConvertible Unsec Loan Stock - Suspension Notice
8th May 20138:49 amRNSAdditional Listing
15th Apr 20132:44 pmRNSNet Asset Value(s)
12th Mar 20139:37 amRNSNet Asset Value(s)
26th Feb 20139:43 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.